Focused Ultrasound Therapy

Clinical Trials SquareFocused ultrasound is an early-stage, noninvasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with sacral chordomas. This novel technology focuses beams of ultrasound energy precisely and accurately on targets deep in the brain without damaging surrounding normal tissue. Where the beams converge, the ultrasound produces precise ablation (thermal destruction of tissue) enabling sacral chordomas to be treated without surgery.

Focused ultrasound has been used to treat four patients with sacral chordomas in England with encouraging results. The researchers report tumor volume was reduced over time in three patients for whom follow up scans were available. Tumor necrosis was documented in two out of the three patients.

The primary options for treatment of sacral chordomas include invasive surgery.

For certain patients, focused ultrasound could provide a noninvasive alternative to surgery with less risk of complications and lower cost. This is particularly important as even with best efforts, chodomas can see the surgical wound and recur.

Advantages:

  • Focused ultrasound is noninvasive, so it does not carry added concerns like surgical wound healing or infection. 
  • Focused ultrasound can reach the desired target without damaging surrounding tissue.
  • It can be repeated, if necessary.

Clinical Trials

There is a clinical trial treating patients in the UK for sacral chordomas. This trial is only open to citizens of the UK. 

Regulatory Approval and Reimbursement 

Focused ultrasound treatment for sacral chordoma is not yet approved by regulatory bodies or covered by medical insurance companies.

Patient Advocacy 

The Chordoma Foundation is a nonprofit organization working to improve the lives of those affected by chordoma and lead the search for a cure.

Notable Papers

Gillies MJ, Lyon PC, Wu F, Leslie T, Chung DY, Gleeson F, Cranston D, Bojanic S. High-intensity focused ultrasonic ablation of sacral chordoma is feasible: a series of four cases and details of a national clinical trial. Br J Neurosurg. 2016 Dec 12:1-6.

Click here for additional references from PubMed.

 

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email